BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16271962)

  • 1. Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?
    Al-Saleem T; Balsara BR; Liu Z; Feder M; Testa JR; Wu H; Greenberg RE
    Cancer Genet Cytogenet; 2005 Nov; 163(1):81-5. PubMed ID: 16271962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
    Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
    J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.
    Brown JA; Takahashi S; Alcaraz A; Borell TJ; Anderl KL; Qian J; Persons DL; Bostwick DG; Lieber MM; Jenkins RB
    J Urol; 1996 Jul; 156(1):31-5. PubMed ID: 8648831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
    Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G
    Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of renal oncocytosis: a possible model for neoplastic progression.
    Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
    Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
    Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
    Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of oncocytic papillary renal cell carcinoma.
    Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
    Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
    Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
    Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical chromosomal aberrations in papillary renal cortical tumors: relationship with histopathologic features.
    Henke RP; Erbersdobler A
    Virchows Arch; 2002 Jun; 440(6):604-9. PubMed ID: 12070600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial papillary renal carcinoma: cytogenetic characterization in normal and tumor tissues in two brothers. A case report.
    Gallucci M; Vico E; Sentinelli S; Leonardo C; Visca P; Orlandi G; Cianciulli A
    Urol Oncol; 2008; 26(3):295-8. PubMed ID: 18452823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
    Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
    Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.
    Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G
    Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
    Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization.
    Picken MM; Chyna B; Flanigan RC; Lee JM
    Am J Clin Pathol; 2008 Mar; 129(3):377-82. PubMed ID: 18285259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.